galantamine and cotinine

galantamine has been researched along with cotinine in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Adam, BL; Gao, J; Terry, AV	1
Curtis, MA; Lin, SX; Sperry, J	1
Batra, A; Croissant, B; Diehl, A; Mann, K; Nakovics, H; Smolka, MN	1
Brede, E; MacLean, RR; Sofuoglu, M; Waters, AJ	1

Reviews

1 review(s) available for galantamine and cotinine

Article	Year
Pyridine alkaloids with activity in the central nervous system. Bioorganic & medicinal chemistry, 2020, 12-15, Volume: 28, Issue:24 Topics: Alkaloids; Amphibians; Animals; Bacteria; Central Nervous System Diseases; Fungi; Nicotine; Plants; Pyridines; Receptors, Nicotinic	2020

Trials

2 trial(s) available for galantamine and cotinine

Article	Year
Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial. International journal of clinical pharmacology and therapeutics, 2006, Volume: 44, Issue:12 Topics: Administration, Cutaneous; Adult; Alcoholism; Cholinesterase Inhibitors; Cotinine; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Sex Factors; Skin Diseases; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome	2006
Effects of galantamine on smoking behavior and cognitive performance in treatment-seeking smokers prior to a quit attempt. Human psychopharmacology, 2018, Volume: 33, Issue:4 Topics: Adult; Cholinesterase Inhibitors; Cognition; Cotinine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Nootropic Agents; Patient Acceptance of Health Care; Patient Satisfaction; Smokers; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome	2018

Article

Year

Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial.

International journal of clinical pharmacology and therapeutics, 2006, Volume: 44, Issue:12

Topics: Administration, Cutaneous; Adult; Alcoholism; Cholinesterase Inhibitors; Cotinine; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Sex Factors; Skin Diseases; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome

2006

Effects of galantamine on smoking behavior and cognitive performance in treatment-seeking smokers prior to a quit attempt.

Human psychopharmacology, 2018, Volume: 33, Issue:4

Topics: Adult; Cholinesterase Inhibitors; Cognition; Cotinine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Nootropic Agents; Patient Acceptance of Health Care; Patient Satisfaction; Smokers; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome

2018

Other Studies

2 other study(ies) available for galantamine and cotinine

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease. Bioorganic & medicinal chemistry letters, 2014, Mar-15, Volume: 24, Issue:6 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Cotinine; Humans; Neurons; Neuroprotective Agents; Nicotine; Peptide Fragments; Rats; Receptors, N-Methyl-D-Aspartate	2014